Insider Selling: Arteris (NASDAQ:AIP) COO Sells 12,219 Shares of Company Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 12,219 shares of Arteris stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $24.29, for a total transaction of $296,799.51. Following the sale, the chief operating officer directly owned 194,659 shares in the company, valued at $4,728,267.11. This trade represents a 5.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Price Performance

NASDAQ:AIP traded up $0.16 on Tuesday, hitting $24.13. The company had a trading volume of 476,272 shares, compared to its average volume of 728,847. Arteris, Inc. has a 52 week low of $12.06 and a 52 week high of $50.26. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of $1.19 billion, a price-to-earnings ratio of -27.74 and a beta of 1.90. The firm has a 50 day moving average of $24.73 and a two-hundred day moving average of $28.61.

Arteris (NASDAQ:AIP) last posted its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%.The company had revenue of $24.13 million for the quarter, compared to the consensus estimate of $23.48 million. On average, research analysts anticipate that Arteris, Inc. will post -0.68 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Roth Capital began coverage on Arteris in a research note on Tuesday, August 4th. They set a “buy” rating and a $40.00 price target on the stock. Weiss Ratings raised shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 21st. Rosenblatt Securities reaffirmed a “buy” rating and set a $38.00 target price on shares of Arteris in a research report on Friday, August 7th. Jefferies Financial Group upgraded Arteris from a “hold” rating to a “buy” rating and upped their price target for the company from $35.00 to $50.00 in a research report on Friday, August 7th. Finally, Oppenheimer began coverage on Arteris in a research note on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price target for the company. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $39.43.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
• Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
• Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Institutional Investors Weigh In On Arteris

Several large investors have recently modified their holdings of AIP. BlackRock Inc. acquired a new position in Arteris in the second quarter valued at $160,129,000. Needham Investment Management LLC grew its holdings in Arteris by 2.6% during the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after acquiring an additional 86,500 shares during the period. Wellington Management Group LLP raised its position in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after acquiring an additional 1,897 shares in the last quarter. Granahan Investment Management LLC raised its position in shares of Arteris by 201.0% in the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock worth $11,723,000 after acquiring an additional 476,181 shares in the last quarter. Finally, Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter valued at about $11,602,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.